These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15475809)

  • 21. What is cardiac resynchronization therapy?
    Barold SS
    Am J Med; 2001 Aug; 111(3):224-32. PubMed ID: 11530034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis.
    Shah RM; Patel D; Molnar J; Ellenbogen KA; Koneru JN
    Europace; 2015 Feb; 17(2):267-73. PubMed ID: 25164431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging.
    Eldadah ZA; Rosen B; Hay I; Edvardsen T; Jayam V; Dickfeld T; Meininger GR; Judge DP; Hare J; Lima JB; Calkins H; Berger RD
    Heart Rhythm; 2006 Apr; 3(4):435-42. PubMed ID: 16567291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.
    Ruwald AC; Kutyifa V; Ruwald MH; Solomon S; Daubert JP; Jons C; Brenyo A; McNitt S; Do D; Tanabe K; Al-Ahmad A; Wang P; Moss AJ; Zareba W
    Eur Heart J; 2015 Feb; 36(7):440-8. PubMed ID: 25112662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac resynchronization therapy in congestive heart failure: Ready for prime time?
    Manolis AS
    Heart Rhythm; 2004 Sep; 1(3):355-63. PubMed ID: 15851184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular-only pacing in heart failure patients with normal atrioventricular conduction improves global function and left ventricular regional mechanics compared with biventricular pacing: an adaptive cardiac resynchronization therapy sub-study.
    Burns KV; Gage RM; Curtin AE; Gorcsan J; Bank AJ
    Eur J Heart Fail; 2017 Oct; 19(10):1335-1343. PubMed ID: 28653458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiac resynchronization therapy in terminal heart failure: current status and prospects].
    Sack S; Heinzel F; Dagres N; Wieneke H; Erbel R
    Herz; 2001 Feb; 26(1):84-8. PubMed ID: 11258115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heart re-synchronization with biventricular stimulation: new treatment for refractory heart failure].
    Daubert JC; Leclercq C; Mabo P
    Bull Acad Natl Med; 2002; 186(1):45-55; discussion 56-7. PubMed ID: 12146141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
    Berger R; Shankar A; Fruhwald F; Fahrleitner-Pammer A; Freemantle N; Tavazzi L; Cleland JG; Pacher R
    Eur Heart J; 2009 Sep; 30(17):2109-16. PubMed ID: 19493864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into cardiac resynchronization therapy.
    Epstein AE
    Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I45-50. PubMed ID: 16450812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
    Young JB; Abraham WT; Smith AL; Leon AR; Lieberman R; Wilkoff B; Canby RC; Schroeder JS; Liem LB; Hall S; Wheelan K;
    JAMA; 2003 May; 289(20):2685-94. PubMed ID: 12771115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; PisanĂ² EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term efficacy of implantable cardiac resynchronization therapy plus defibrillator for primary prevention of sudden cardiac death in patients with mild heart failure: an updated meta-analysis.
    Sun WP; Li CL; Guo JC; Zhang LX; Liu R; Zhang HB; Zhang L
    Heart Fail Rev; 2016 Jul; 21(4):447-53. PubMed ID: 27043219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac resynchronization therapy: which device to implant?
    Leclercq C; Mabo C; Daubert JC
    Arch Cardiovasc Dis; 2008 Jan; 101(1):55-60. PubMed ID: 18391874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.